INJ’s $100M Fund: A Glorious Misadventure or a Precursor to Plunge? 🤔💰

by

On the morose Tuesday, September 2, the INJ price, much to the delight of its few remaining enthusiasts, managed a tepid 3.6% ascent. This modest rally was attributed to the ever-so-slightly growing Injective Digital Asset Treasury, a fund so grand it boasts a staggering $100 million, earmarked for the accumulation of the INJ token. 🎉

  • Injective’s price, despite the fanfare, teeters on the brink of a precipitous decline. 📉
  • A menacing rising wedge chart pattern looms ominously on the daily chart. ⚠️
  • The Injective Digital Asset Treasury, flush with $100 million, has officially launched, drawing in the usual suspects of institutional investors. 💼

Injective (INJ) soared to the dizzying heights of $12.90, marking an impressive 4% recovery from its nadir earlier in the week. However, this minor victory dance is but a faint echo of its former glory, as the token remains a mere shadow of its November self, having lost over 60% of its value. 😢

The INJ price rally was fueled by the Injective Digital Asset Treasury, a financial marvel that has managed to seduce a coterie of high-profile investors, including the illustrious FalconX, Monarq, Canary Capital, and the venerable Kraken. Collectively, these firms oversee a staggering $30 billion in assets under management, a sum so vast it could buy out several small countries. 🌍💰

The $100 Million Injective Digital Asset Treasury has attracted investments from major institutions across both traditional finance and crypto.

All net proceeds will be used to accumulate $INJ directly from secondary markets.

Investors in the round include FalconX, Monarq,…

– Injective 🥷 (@injective) September 2, 2025

This latest development coincides with a broader trend of corporations amassing cryptocurrencies. Over 100 public companies now hold nearly 1 million Bitcoin (BTC), a figure that would make even Scrooge McDuck envious. 🦆 Additionally, companies have been snapping up other top tokens like Ethereum, Tron, and XRP, as if they were on sale at a Black Friday event. 🛍️

The INJ price also received a modest boost from the prospect of a spot Injective ETF. The SEC, in its infinite wisdom, has opened the comment period for the INJ ETF, a move that could theoretically stoke demand for the coin. 🚀

However, the cold, hard truth remains: Injective is still a bit player in the sprawling crypto industry. According to DeFi Llama, the network’s total value locked has dwindled to a meager $80 million, a far cry from its peak of $158 million last year. 📉 The network processed a paltry $898,000 in decentralized exchange volume in the past 24 hours, with stablecoin volume barely registering at $26 million. 🤦‍♂️

INJ Price Technical Analysis

The daily chart reveals a rather grim picture. The INJ price hit a high of $16.46 in August before plummeting to a low of $12.1. It currently hovers just below the 50-day and 100-day exponential moving averages, a position that suggests a bearish sentiment. 🐻

Injective has also formed a rising wedge pattern, characterized by two ascending and converging trendlines that are on the verge of meeting. The MACD lines have dipped below the zero line, a clear bearish signal. 🚨

In summary, the token is poised for a bearish breakout, potentially sliding to support at $10, a 21% drop from its current level. Alternatively, it might muster the strength to retest the upper boundary of the channel at $16.46, but one can only hope. 🙏

Read More

2025-09-02 21:56